Skip to content

Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression

Braining - A Randomized Controlled Study on Moderate-vigorous Aerobic Physical Exercise (PE) as an add-on Treatment in Bipolar Disorder. Effects on Recovery Time and Long-term Prevention From Bipolar Depression

Status
Suspended
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05340686
Enrollment
54
Registered
2022-04-22
Start date
2022-10-26
Completion date
2029-04-20
Last updated
2026-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Affective Disorder, Currently Depressed, Moderate, Bipolar Affective Disorder; Remission in, Bipolar Depression, Bipolar Disorder, Bipolar I Disorder, Bipolar II Disorder

Keywords

physical exercise, physical activity

Brief summary

Hypothesis: the hypothesis of the study is that aerobic physical exercise (PE) performed with the method Braining accelerates recovery from bipolar depression as well as improves psychiatric and somatic health in individuals with bipolar depression Method: a randomized controlled trial with 54 patients with bipolar depression are randomized to 6 weeks of either 1) supervised aerobic PE 3 times/week, 2) supervised relaxation/stretching 3 times/week or 3) information about PE but no supervised activity.

Detailed description

The hypothesis of this study is that adding aerobic PE might accelerate recovery, reduce negative side effects, improve mental wellbeing and function, increase long term prevention against relapsing bipolar episodes and reduce risk for complications such as cardiovascular disease in patients with bipolar disorder. Furthermore the study aims to evaluate if the effect of PE is linked to biological factors such as genetical factors, stress hormone levels, level of inflammation and other biological markers for health and disease that can be measured in standard blood samples. Patients diagnosed with bipolar disorder with ongoing depression are invited to participate in the study at regular visits in the psychiatric clinic. All study participants are medicated with mood stabilizers according to routine treatment and receive regular treatment for bipolar depression. After informed consent the study participants will be randomized to one of three groups 1) moderate to vigorous PE group training together with psychiatric staff three times per week 2) relaxing and stretching exercises group training together with psychiatric staff three times per week 3) information about PE and relaxation but no supervised PE or relaxation/stretching, for the 6 weeks of the study period. BEFORE: The first week consists of pre-test including interview regarding medical history and physical and psychiatric examination, ECG and blood samples. To measure level of physical activity the participants wear an activity monitor, Actiheart, that continuously registers physical activity for 7 days. The study participants will also fill out different questionnaires regarding general health and psychiatric symptoms. STUDY PERIOD: During the 6 weeks long study period the participants fill out an activity questionnaire and health questionnaires once a week. AFTER: during the sixth week of the study period evaluation is being performed with repetition of the physical and psychiatric examination, blood samples and questionnaires. After 1, 2 and 3 years after the exercise period the questionnaires are repeated. Blood samples are repeated one year after the study period.

Interventions

Moderate to vigorous physical exercise 30-45 minutes in a group setting led by psychiatric staff, 3 times per week for 6 weeks

BEHAVIORALRelaxing Physical Exercise

Relaxing exercises (stretching, light yoga) 30-45 minutes in a group setting led by psychiatric staff, 3 times per week for 6 weeks

BEHAVIORALInformation about physical exercise

Written and oral information about physical exercise recommendations, on one occasion, by researcher

Sponsors

Region Stockholm
Lead SponsorOTHER_GOV
Karolinska Institutet
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients at Psychiatry Southwest, Karolinska University Hospital Region Stockholm Sweden. * Bipolar disorder * Ongoing depression, defined as a PHQ-9 score of 9 or higher at any occasion 2 weeks before inclusion.

Exclusion criteria

* Severe psychiatric disorder such as mania and psychosis * Medical conditions such as heart- and lung diseases where PE is contraindicated. * Unable to understand written and spoken Swedish language.

Design outcomes

Primary

MeasureTime frameDescription
PHQ-9 (Patient Health Questionnaire - 9 items)Change from inclusion to follow up 6 weeks after inclusionSelf rated depressive symptoms. Minimum value 0, maximum value 27, where higher values indicate more depressive symptoms.

Secondary

MeasureTime frameDescription
MADRS (Montgomery-Åsberg Depression Rating Scale)Change from inclusion to follow up 6 weeks after inclusionClinician-rated scale to assess degree of depressive symptoms. 10 items. Minimum value 0 and maximum value 60, where higher values indicate more depressive symptoms.
AS-18 (Affective self rating scale)Change from inclusion to follow up 6 weeks after inclusionSelf-assessment of symptoms of depression and hypomania/mania. 9 items for depression and 9 items for mania. Score 0-72. A score of over 10 on the depressive or manic/hypomanic subscale should give rise to suspicion of ongoing depression and hypomania/mania respectively. Scores of over 10 on both the depressive and manic/hypomanic scale at the same time give may indicate an affective mixed state.
YMRS (Young Ziegler Mania Rating Scale)Change from inclusion to follow up 6 weeks after inclusionInterviewer-rated scale. Includes 11 items; seven are rated from 0 (absent) to 4; four from 0 to 8; total scores range from 0 to 60. A higher value indicates worse symptoms of hypomania/mania.
CGI-S (Clinical Global Impressions - Severity Scale)Change from inclusion to follow up 6 weeks after inclusionA one-item clinician assessed measure which evaluates the severity of psychopathology from 1 to 7, where 1 is 'normal' and 7 is 'among the most extremely ill patients' by the question "Considering your total clinical experience with this particular population, how mentally ill is the patient at this time?".
Blood pressureChange from inclusion to follow up 6 weeks after inclusionsystolic and diastolic, mmHg
Heart rateChange from inclusion to follow up 6 weeks after inclusionHeart rate, beats per minute
BMI (Body mass index)Change from inclusion to follow up 6 weeks after inclusionWeight in kg divided by the square of height in m
Waist circumferenceChange from inclusion to follow up 6 weeks after inclusionWaist circumference, cm
FBS (fasting blood sugar)Change from inclusion to follow up 6 weeks after inclusionfasting blood sugar, mmol/l
HbA1c (Hemoglobin A1c)Change from inclusion to follow up 6 weeks after inclusionGlycated hemoglobin, mmol/mol
Blood lipidsChange from inclusion to follow up 6 weeks after inclusionTotal cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, mmol/L
CRP (C-reactive protein)Change from inclusion to follow up 6 weeks after inclusionMeasurement of inflammation and infection, mmol/L
Telomere lengthChange from inclusion to follow up 6 weeks after inclusiontelomere length in leukocytes
TelomeraseChange from inclusion to follow up 6 weeks after inclusionEnzyme activity in blood
WHODAS 2.0 (World health organization disability assessment schedule)Change from inclusion to follow up 6 weeks after inclusionSelf rated disability. Minimum value 0, maximum value 100, where higher values indicate more disability.
EQ-5D-5L (EuroQol VAS)Change from inclusion to follow up 6 weeks after inclusionSelf-assessment instrument for describing and valuing health. Defines health in terms of five dimensions: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Also included is an overall health rating on a 0-100 hash-marked, vertical visual analogue scale (EQ-VAS). Assessment the scores from the descriptive component can be reported as a five digit number ranging from 11111 (full health) to 55555 (worst health). A number of methods exist for analysing these five digit profiles. However, frequently they are converted to a single utility index using country specific value sets. A higher index number indicates a poorer self-assessed health.
SRH (Self-rated health)Change from inclusion to follow up 6 weeks after inclusionSRH is typically measured as a single-item, the most common wording of which is "In general, would you say your health is" with the response items "excellent," "very good," "good," "fair," or "poor."
BBQ (Brunnsviken Brief Quality of Life Questionnaire)Change from inclusion to follow up 6 weeks after inclusionSelf rated quality of life. Minimum value 0, maximum value 96, where higher values indicate higher quality of life satisfaction.
Occupational level measured in % of work ability in medical certificateChange from inclusion to follow up 6 weeks after inclusionComplete sick leave 0%, partial sick leave 25-75 %, completely able to work 100%.

Countries

Sweden

Contacts

PRINCIPAL_INVESTIGATORLina Martinsson, PhD

Karolinska Institutet

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026